Désirèe Deandreis

7.0k total citations · 2 hit papers
130 papers, 4.3k citations indexed

About

Désirèe Deandreis is a scholar working on Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Désirèe Deandreis has authored 130 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Endocrinology, Diabetes and Metabolism, 53 papers in Radiology, Nuclear Medicine and Imaging and 39 papers in Surgery. Recurrent topics in Désirèe Deandreis's work include Thyroid Cancer Diagnosis and Treatment (47 papers), Radiomics and Machine Learning in Medical Imaging (27 papers) and Neuroendocrine Tumor Research Advances (24 papers). Désirèe Deandreis is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (47 papers), Radiomics and Machine Learning in Medical Imaging (27 papers) and Neuroendocrine Tumor Research Advances (24 papers). Désirèe Deandreis collaborates with scholars based in France, Italy and Switzerland. Désirèe Deandreis's co-authors include Sophie Leboulleux, Éric Baudin, Martin Schlumberger, Abir Al Ghuzlan, Isabelle Borget, J. Lumbroso, Ettore Pelosi, Dana M. Hartl, C. Chougnet and Caroline Caramella and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Désirèe Deandreis

122 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer

2013 555 citations Désirèe Deandreis et al. profile →
Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer

2012 448 citations Martin Schlumberger, Isabelle Borget et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Désirèe Deandreis France	36	2.4k	1.6k	1.1k	971	723	130	4.3k
Luca Ceriani Switzerland	35	1.6k 0.7×	1.1k 0.7×	1.1k 1.0×	518 0.5×	499 0.7×	194	3.5k
Vittoria Rufini Italy	34	1.2k 0.5×	1.2k 0.8×	1.1k 0.9×	975 1.0×	1.2k 1.7×	181	3.8k
Stéphane Bardet France	33	1.7k 0.7×	1.1k 0.7×	1.3k 1.1×	478 0.5×	394 0.5×	90	3.3k
Jan Tennvall Sweden	35	1.6k 0.7×	895 0.6×	2.3k 2.1×	1.4k 1.5×	647 0.9×	130	4.9k
Clive Harmer United Kingdom	42	2.6k 1.1×	1.7k 1.1×	806 0.7×	1.2k 1.2×	593 0.8×	138	4.9k
Francesco Bertagna Italy	33	776 0.3×	962 0.6×	1.6k 1.4×	695 0.7×	422 0.6×	295	3.8k
C Parmentier France	35	3.1k 1.3×	1.4k 0.9×	825 0.7×	1.1k 1.1×	676 0.9×	154	4.7k
Bart de Keizer Netherlands	35	690 0.3×	1.1k 0.7×	1.4k 1.2×	708 0.7×	431 0.6×	158	3.5k
Mira Milas United States	36	1.1k 0.5×	1.7k 1.1×	247 0.2×	955 1.0×	527 0.7×	95	3.5k
Anju Sahdev United Kingdom	33	2.0k 0.8×	2.6k 1.6×	609 0.5×	270 0.3×	248 0.3×	97	4.2k

Countries citing papers authored by Désirèe Deandreis

Since Specialization

Citations

This map shows the geographic impact of Désirèe Deandreis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Désirèe Deandreis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Désirèe Deandreis more than expected).

Fields of papers citing papers by Désirèe Deandreis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Désirèe Deandreis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Désirèe Deandreis. The network helps show where Désirèe Deandreis may publish in the future.

Co-authorship network of co-authors of Désirèe Deandreis

This figure shows the co-authorship network connecting the top 25 collaborators of Désirèe Deandreis. A scholar is included among the top collaborators of Désirèe Deandreis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Désirèe Deandreis. Désirèe Deandreis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cao, Christine Do, Niki Christou, Julien Hadoux, & Désirèe Deandreis. (2025). Chapter 8: Management of aggressive forms of primary HPT: Parathyroid carcinoma and atypical parathyroid tumor. Annales d Endocrinologie. 86(1). 101697–101697.

Porcelli, Tommaso, Sophie Moog, Julien Hadoux, et al.. (2025). Validation of the International Medullary Thyroid Carcinoma Grading System in Patients with Distant Metastases. Thyroid. 35(11). 1268–1276.

Pouget, Jean‐Pierre, Pablo Mínguez Gabiña, Ken Herrmann, et al.. (2024). EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose–response and threshold absorbed doses. European Journal of Nuclear Medicine and Molecular Imaging. 52(3). 1210–1222. 4 indexed citations

Rovera, Guido, Séréna Grimaldi, Marco Oderda, et al.. (2024). Comparative Performance of 68Ga-PSMA-11 PET/CT and Conventional Imaging in the Primary Staging of High-Risk Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy. Diagnostics. 14(17). 1964–1964. 5 indexed citations

Rubatto, Marco, Franco Picciotto, Giovenale Moirano, et al.. (2023). Sentinel Lymph Node Biopsy in Malignant Melanoma of the Head and Neck: A Single Center Experience. Journal of Clinical Medicine. 12(2). 553–553. 1 indexed citations

Rovera, Guido, Séréna Grimaldi, Marco Oderda, et al.. (2023). Machine Learning CT-Based Automatic Nodal Segmentation and PET Semi-Quantification of Intraoperative 68Ga-PSMA-11 PET/CT Images in High-Risk Prostate Cancer: A Pilot Study. Diagnostics. 13(18). 3013–3013. 6 indexed citations

Garo, Maria Luisa, Désirèe Deandreis, Alfredo Campennì, et al.. (2023). Accuracy of papillary thyroid cancer prognostic nomograms: a systematic review. Endocrine Connections. 12(4). 2 indexed citations

Balma, Michele, Virginia Liberini, Ambra Buschiazzo, et al.. (2023). The Role of Theragnostics in Breast Cancer: A Systematic Review of theLast 12 Years. Current Medical Imaging Formerly Current Medical Imaging Reviews. 19(8). 817–831. 9 indexed citations

Giovanella, Luca, Désirèe Deandreis, Alexis Vrachimis, Alfredo Campennì, & Petra Petranović Ovčariček. (2022). Molecular Imaging and Theragnostics of Thyroid Cancers. Cancers. 14(5). 1272–1272. 28 indexed citations

10.

Liberini, Virginia, Marco Rubatto, Roberto Passera, et al.. (2021). Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced Melanoma. Journal of Clinical Medicine. 10(21). 4994–4994. 2 indexed citations

11.

Liberini, Virginia, Riccardo Laudicella, Martina Capozza, et al.. (2021). Molecular Imaging in Immunotherapy: A Systematic Review. Preprints.org. 1 indexed citations

12.

Liberini, Virginia, Riccardo Laudicella, Martina Capozza, et al.. (2021). The Future of Cancer Diagnosis, Treatment and Surveillance: A Systemic Review on Immunotherapy and Immuno-PET Radiotracers. Molecules. 26(8). 2201–2201. 26 indexed citations

13.

Liberini, Virginia, Annapaola Mariniello, Luisella Righi, et al.. (2021). NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to In Vivo Images. Cancers. 13(18). 4543–4543. 22 indexed citations

14.

Polverari, Giulia, Francesco Ceci, Valentina Bertaglia, et al.. (2020). 18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival. Cancers. 12(5). 1163–1163. 77 indexed citations

15.

Terroir, M., Caroline Caramella, Isabelle Borget, et al.. (2019). F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients. Thyroid. 29(10). 1457–1464. 19 indexed citations

16.

Teuff, Gwénaël Le, J. Guigay, Caroline Caramella, et al.. (2017). Antitumour activity of somatostatin analogues in sporadic, progressive, metastatic pulmonary carcinoids. European Journal of Cancer. 75. 259–267. 34 indexed citations

17.

Elaidi, Réza, Yann Vano, Nicolas Aide, et al.. (2016). Phase I/II dose-finding, safety and efficacy study of radium-223 dichloride in renal cell carcinoma patients with bone metastases. Annals of Oncology. 27. vi295–vi295. 36 indexed citations

18.

Deutsch, Éric, C. Le Péchoux, Laurence Faivre, et al.. (2015). Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer. Annals of Oncology. 26(6). 1223–1229. 42 indexed citations

19.

Ayala‐Ramirez, Montserrat, C. Chougnet, Mouhammed Amir Habra, et al.. (2012). Treatment with Sunitinib for Patients with Progressive Metastatic Pheochromocytomas and Sympathetic Paragangliomas. The Journal of Clinical Endocrinology & Metabolism. 97(11). 4040–4050. 144 indexed citations

20.

Leboulleux, Sophie, Désirèe Deandreis, Abir Al Ghuzlan, et al.. (2010). Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis?. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact